DERM
Journey Medical Corp
NASDAQ: DERM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.15
+3.00% today
Updated 2026-04-30
Market cap
$171.27M
P/E ratio
—
P/S ratio
2.77x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$4 – $10
Volume
0.2M
Journey Medical Corp (DERM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-10.6%
Last 4 quarters
Revenue YoY growth
+18.1%
Most recent quarter
EPS YoY growth
-140.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-11.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-15.0%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-0.04 | +0.0% | $7.12 | $6.63 | -6.9% |
| 2025-11-12 | $-0.09 | -200.0% | $9.05 | $7.69 | -15.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.04 | $-0.04 | +0.0% | $16.08M | +18.1% |
| 2025-09-30 | $-0.03 | $-0.09 | -200.0% | $17.63M | +20.5% |
| 2025-06-30 | $-0.11 | $-0.16 | -45.5% | $15.01M | +1.0% |
| 2025-03-31 | $-0.24 | $-0.18 | +24.2% | $13.14M | +0.8% |
| 2024-12-31 | $-0.17 | $0.10 | +158.0% | $13.62M | -10.7% |
| 2024-09-30 | $-0.17 | $-0.12 | +29.4% | $14.63M | -57.6% |
| 2024-06-30 | $-0.15 | $-0.17 | -13.3% | $14.86M | -13.5% |
| 2024-03-31 | $-0.23 | $-0.53 | -130.4% | $13.03M | +6.7% |
| 2023-12-31 | $-0.08 | $-0.12 | -50.0% | $15.26M | — |
| 2023-09-30 | $-0.15 | $0.80 | +633.3% | $34.54M | — |
| 2023-06-30 | $-0.33 | $-0.29 | +12.1% | $17.17M | — |
| 2023-03-31 | $-0.45 | $-0.57 | -26.7% | $12.21M | — |
Frequently asked questions
Has Journey Medical Corp beaten earnings estimates?
Journey Medical Corp has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -10.6% over the last 2 quarters.
How does DERM stock react to earnings?
DERM stock has moved an average of -11.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Journey Medical Corp's revenue growth rate?
Journey Medical Corp reported year-over-year revenue growth of +18.1% in its most recent quarter, with EPS growing -140.0% year-over-year.